Disease/Infection News

RSS

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

New research from Boston Medical Center found that providing pragmatic support, specifically rapid access to antiretroviral therapy, pharmacotherapy for opioid use disorder, and strengths-based case management, improved treatment outcomes for people with HIV who inject drugs in St. Petersburg, Russia.

1 Sep 2023

International consortium to study link between RSV infection and chronic respiratory tract diseases

UMC Utrecht will lead an international consortium that will try to answer a key question that's in the mind of many pediatricians, infectiologists, pulmonologists and other health professionals: "Why are children that had an RSV infection in early childhood at increased risk of developing asthma later in life?"

1 Sep 2023

Lessons learned from COVID-19 pandemic can help confront future epidemics

Where did COVID-19 originate? Prof Angus Dalgleish shows that the virus that emerged in Wuhan, China in 2019 had been modified in a laboratory to make it more infectious (for the construction of a more effective vaccine).

1 Sep 2023

Biomarkers unveil insights into post-COVID-19 syndrome variability

Researchers studied a prospective observation cohort of patients with post-coronavirus disease 2019 syndrome.

1 Sep 2023

Activist misuses federal data to make false claim that covid vaccines killed 676,000

A blog post shared on Facebook claimed that covid-19 vaccines have killed some 676,000 Americans.

1 Sep 2023

New insights into how lung cells detect influenza virus

Researchers from Trinity College Dublin have discovered some new and surprising ways that viral RNA and influenza virus are detected by human lung cells, which has potential implications for treating people affected by such viruses.

31 Aug 2023

Scientists delve deeper into how vaccines work against leishmaniasis

Scientists have established the effectiveness of vaccines they developed to prevent the disfiguring skin disease leishmaniasis in animal studies, and Phase 1 human trial planning is in motion for the most promising candidate.

31 Aug 2023

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

The study tracks the long-term kinetics of antibody responses to SARS-CoV-2 after vaccination and infections in New York healthcare workers from 2020 to 2023. It reveals that antibody waning is slower after booster shots, but there's an upper limit to antibody levels, which gradually lowers with repeated SARS-CoV-2 exposures and vaccinations.

31 Aug 2023

Is the rapid evolution of SARS-CoV-2 in white-tailed deer complicating our fight against the pandemic?

New study reveals rapid evolution of SARS-CoV-2 in Ohio's white-tailed deer population, with a 25% seroprevalence rate. The findings suggest a significant risk of animal-to-human transmission and indicate the virus evolves faster in deer than in humans.

31 Aug 2023

Cracking the code on post-vaccine COVID protection

The study investigates the relationship between antibody levels and behavioral factors in 176 adults vaccinated with Pfizer's BNT162b2, finding that higher levels of specific antibodies correlate with greater protection against symptomatic COVID-19. It also suggests that current commercial assays may need reformatting for better risk prediction.

31 Aug 2023

Coronavirus fusion peptide plays more invasive role in infection than previously thought

Although the COVID-19 pandemic was the first time most of humanity learned of the now infamous disease, the family of coronaviruses was first identified in the mid-1960s.

31 Aug 2023

Dectin-1 stimulation promotes pro-inflammatory response in HIV-positive individuals

A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 16, entitled, "Dectin-1 stimulation promotes a distinct inflammatory signature in the setting of HIV-infection and aging."

31 Aug 2023

Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Researchers evaluated the efficacy of semaglutide in patients with the obesity phenotype of heart failure and preserved ejection fraction.

31 Aug 2023

Study suggests sepsis as a considerable burden to public health

A research team at Lund University in Sweden has found that more than four percent of all hospital admissions in southern Sweden are associated with sepsis.

31 Aug 2023

New omicron variants can reinfect people who were infected with earlier variants

The omicron variants of the SARS-CoV-2 virus, which have rapidly spread around the world over the past year, latch onto our cells more tightly, invade them more efficiently, and elude many of the antibodies induced by previous infections and vaccines.

30 Aug 2023

Study finds potential HIV cure using existing cancer drug

An existing blood cancer drug has shown promise in killing 'silent' HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease.

30 Aug 2023

Flu and COVID-19 vaccine programs to start earlier than planned in England

This year's autumn flu and COVID-19 vaccine programmes will start earlier than planned in England as a precautionary measure following the identification of a new COVID-19 variant.

30 Aug 2023

Engineered ACE2 decoy shows promise as COVID-19 treatment

Researchers from Japan demonstrated that an engineered angiotensin-converting enzyme 2 (ACE2) receptor, which showed the potential to remarkably reduce the emergence of resistant virus strains, could successfully exert its therapeutic effect in primates, which may open avenues for the application of the technology for the treatment of humans.

30 Aug 2023

Study finds association between high dietary phosphorus and breast cancer

Researchers evaluated associations of breast cancer incidence with different dietary phosphate levels.

30 Aug 2023

Comparative mortality rates of SARS-CoV-2 and influenza in France before and after the COVID-19 pandemic

Researchers investigate the contribution of SARS-CoV-2 and influenza to hospitalizations and mortality to inform future vaccination and treatment policies.

30 Aug 2023

Disease/Infection News

Integrating HIV and addiction treatment improves outcomes for people who inject drugs in Russia

International consortium to study link between RSV infection and chronic respiratory tract diseases

Lessons learned from COVID-19 pandemic can help confront future epidemics

Biomarkers unveil insights into post-COVID-19 syndrome variability

Activist misuses federal data to make false claim that covid vaccines killed 676,000

New insights into how lung cells detect influenza virus

Scientists delve deeper into how vaccines work against leishmaniasis

Boosters slow antibody waning but hit a ceiling: Long-term COVID study reveals limits of immunity

Is the rapid evolution of SARS-CoV-2 in white-tailed deer complicating our fight against the pandemic?

Cracking the code on post-vaccine COVID protection

Coronavirus fusion peptide plays more invasive role in infection than previously thought

Dectin-1 stimulation promotes pro-inflammatory response in HIV-positive individuals

Study finds semaglutide provides benefits for patients with obesity phenotype of heart failure and HFpEF

Study suggests sepsis as a considerable burden to public health

New omicron variants can reinfect people who were infected with earlier variants

Study finds potential HIV cure using existing cancer drug

Flu and COVID-19 vaccine programs to start earlier than planned in England

Engineered ACE2 decoy shows promise as COVID-19 treatment

Study finds association between high dietary phosphorus and breast cancer

Comparative mortality rates of SARS-CoV-2 and influenza in France before and after the COVID-19 pandemic

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News